Drug Class:

Clarithromycin belongs to the macrolide class of antibiotics, renowned for their broad-spectrum activity against Gram-positive and Gram-negative bacteria. It is a bacteriostatic agent that inhibits bacterial protein synthesis, effectively halting the growth and proliferation of susceptible pathogens.

Formulations:

Clarithromycin Dry Syrup (DS): Available in strengths of 125mg/5ml and 250mg/5ml, our Clarithromycin DS provides a convenient oral solution for pediatric patients and those who have difficulty swallowing tablets.

Clarithromycin Tablets: Offered in strengths of 250mg and 500mg, our Clarithromycin Tablets provide precise dosing for adult patients, ensuring optimal therapeutic outcomes.

Clarithromycin General Dry Powder for Injection: Each vial contains 500mg of Clarithromycin, formulated for intravenous administration in the management of severe infections.

Packing Specifications:

• Clarithromycin Dry Syrup is packaged in 60ml bottles, providing easy and accurate measurement for pediatric dosing.
• Clarithromycin Tablets are presented in blister packs containing 10 tablets, facilitating convenient storage and administration.
• Clarithromycin General Dry Powder for Injection is provided in single-dose vials, ensuring sterility and potency during administration.

Indications:

Clarithromycin is indicated for the treatment of various bacterial infections, including:

• Community-acquired pneumonia
• Acute bacterial sinusitis
• Acute exacerbations of chronic bronchitis
• Pharyngitis and tonsillitis
• Skin and soft tissue infections
• Helicobacter pylori eradication in peptic ulcer disease

Usage:

• Clarithromycin should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria.
• The choice of dosage and duration of treatment should be based on the type and severity of the infection, as well as the susceptibility of the causative organism.
• Oral formulations can be administered with or without food, depending on patient preference and tolerability.
• Intravenous Clarithromycin should be administered by a healthcare professional and reconstituted according to the manufacturer’s instructions.

Dosage:

• The recommended dosage of Clarithromycin varies depending on the type of infection and the patient’s age and weight.
• Dosage adjustments may be necessary in patients with impaired renal or hepatic function to ensure appropriate drug levels and minimize the risk of adverse effects.

Side Effects:

• Common side effects of Clarithromycin may include:
• Gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain
• Headache
• Skin rash or itching
• Changes in taste perception
• Serious adverse effects such as hepatotoxicity, QT prolongation, and allergic reactions may occur but are rare. Monitoring of liver function and cardiac parameters is recommended during therapy.

Packing Specifications:

• Clarithromycin Dry Syrup is packaged in 60ml bottles, providing easy and accurate measurement for pediatric dosing.
• Clarithromycin Tablets are presented in blister packs containing 10 tablets, facilitating convenient storage and administration.
• Clarithromycin General Dry Powder for Injection is provided in single-dose vials, ensuring sterility and potency during administration.

Experience the efficacy and safety of AIT Pharmaceuticals Division’s Clarithromycin Range in the treatment of bacterial infections. For more information, please contact us.